MDMA showed 'meaningful improvement' in PTSD symptoms, but attributing its benefits amid psychotherapy makes assessment challenging.
Concerns include bias from patients knowing they received MDMA, safety risks like heart and liver issues, and insufficient evidence from clinical trials.
[
add
]
[
|
|
...
]